In This Article:
BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $235.5 million in its fourth quarter.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of $1.32.
The results did not meet Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.15 per share.
The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $104.4 million in the period, beating Street forecasts. Five analysts surveyed by Zacks expected $104.3 million.
For the year, the company reported a loss of $913.8 million, or $5.57 per share. Revenue was reported as $363.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM